Literature DB >> 9400535

Hormone replacement therapy and biological aggressiveness of breast cancer.

K Holli, J Isola, J Cuzick.   

Abstract

Entities:  

Mesh：

Year:  1997        PMID： 9400535     DOI： 10.1016/S0140-6736(05)64308-5

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  3 in total

1.  Breast Cancer Risk in Postmenopausal Women with Medical History of Thyroid Disorder in the Women's Health Initiative.

Authors:  Chien-Hsiang Weng; Erin R Okawa; Mary B Roberts; Sue K Park; Christopher B Umbricht; JoAnn E Manson; Charles B Eaton
Journal:  Thyroid       Date:  2020-02-03       Impact factor: 6.568

2.  High burden of breast cancer in Belgium: recent trends in incidence (1999-2006) and historical trends in mortality (1954-2006).

Authors:  Françoise Renard; Liesbet Van Eycken; Marc Arbyn
Journal:  Arch Public Health       Date:  2011-10-24

3.  Breast cancer with different prognostic characteristics developing in Danish women using hormone replacement therapy.

Authors:  C Stahlberg; A T Pedersen; Z J Andersen; N Keiding; Y A Hundrup; E B Obel; S Møller; F Rank; B Ottesen; E Lynge
Journal:  Br J Cancer       Date:  2004-08-16       Impact factor: 7.640
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.